Impairment of vision in a mouse model of usher syndrome type III

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 3, 2016, Pages 866-875

  Tian, Guilian ^a   Lee, Richard ^a   Ropelewski, Philip ^a   Imanishi, Yoshikazu ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARIN 1; GENOMIC DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; DNA; USH3A PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CILIARY NERVE; CONTROLLED STUDY; DARK ADAPTATION; DNA ISOLATION; ELECTRORETINOGRAPHY; GENOTYPE; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PHOTORECEPTOR; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RETINA ROD; SYNAPSE; TRANSMISSION ELECTRON MICROSCOPY; USHER SYNDROME; VISUAL IMPAIRMENT; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; COLOR VISION; COMPLICATION; DISEASE MODEL; DNA MUTATIONAL ANALYSIS; GENETICS; IMMUNOBLOTTING; KNOCKOUT MOUSE; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; ULTRASTRUCTURE; VISION DISORDERS;

ANIMALS; COLOR VISION; DARK ADAPTATION; DISEASE MODELS, ANIMAL; DNA; DNA MUTATIONAL ANALYSIS; ELECTRORETINOGRAPHY; GENOTYPE; IMMUNOBLOTTING; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; POLYMERASE CHAIN REACTION; RETINA; USHER SYNDROMES; VISION DISORDERS;

EID: 84960157600     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16946     Document Type: Article

References (46)

1. Ness SL, Ben-Yosef T, Bar-Lev A, et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet. 2003;40:767–772.
2. Herrera W, Aleman TS, Cideciyan AV, et al. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci. 2008;49:2651–2660.
3. Pakarinen L, Tuppurainen K, Laippala P, Mantyjarvi M, Puhakka H. The ophthalmological course of Usher syndrome type III. Int Ophthalmol. 1995;19:307–311.
4. Plantinga RF, Pennings RJ, Huygen PL, et al. Visual impairment in Finnish Usher syndrome type III. Acta Ophthalmol Scand. 2006;84:36–41.
5. Adato A, Vreugde S, Joensuu T, et al. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet. 2002;10: 339–350.
6. Fields RR, Zhou G, Huang D, et al. Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet. 2002;71:607–617.
7. Tian G, Zhou Y, Hajkova D, et al. Clarin-1, encoded by the Usher Syndrome III causative gene, forms a membranous microdomain: possible role of clarin-1 in organizing the actin cytoskeleton. J Biol Chem. 2009;284:18980–18993.
8. Geng R, Melki S, Chen DH, et al. The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by Usher syndrome III causative gene. J Neurosci. 2012;32: 9485–9498.
9. Geng R, Geller SF, Hayashi T, et al. Usher syndrome IIIA gene clarin-1 is essential for hair cell function and associated neural activation. Hum Mol Genet. 2009;18:2748–2760.
10. Ogun O, Zallocchi M. Clarin-1 acts as a modulator of mechanotransduction activity and presynaptic ribbon assembly. J Cell Biol. 2014;207:375–391.
11. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet. 2001;2:165–174.
12. Badano JL, Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat Rev Genet. 2002;3: 779–789.
13. Ebermann I, Phillips JB, Liebau MC, et al. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest. 2010;120:1812–1823.
14. Louie CM, Caridi G, Lopes VS, et al. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet. 2010;42:175–180.
15. Reiners J, Nagel-Wolfrum K, Jurgens K, Marker T, Wolfrum U. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res. 2006; 83:97–119.
16. Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 2008;48:433–441.
17. Liu Q, Saveliev A, Pierce EA. The severity of retinal degeneration in Rp1h gene-targeted mice is dependent on genetic background. Invest Ophthalmol Vis Sci. 2009;50: 1566–1574.
18. Danciger M, Yang H, Ralston R, et al. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains. Mol Vis. 2007;13:79–85.
19. Mustafi D, Maeda T, Kohno H, Nadeau JH, Palczewski K. Inflammatory priming predisposes mice to age-related retinal degeneration. J Clin Invest. 2012;122:2989–3001.
20. Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet. 2010;11:273–284.
21. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358:2606–2617.
22. Geller SF, Guerin KI, Visel M, et al. CLRN1 is nonessential in the mouse retina but is required for cochlear hair cell development. PLoS Genet. 2009;5:e1000607.
23. Joensuu T, Hamalainen R, Yuan B, et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet. 2001;69:673–684.
24. Petkov PM, Ding Y, Cassell MA, et al. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res. 2004;14:1806–1811.
25. Yang H, Ding Y, Hutchins LN, et al. A customized and versatile high-density genotyping array for the mouse. Nat Methods. 2009;6:663–666.
26. Mattapallil MJ, Wawrousek EF, Chan CC, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/ 6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci. 2012; 53:2921–2927.
27. MacKenzie D, Arendt A, Hargrave P, McDowell JH, Molday RS. Localization of binding sites for carboxyl terminal specific antirhodopsin monoclonal antibodies using synthetic peptides. Biochemistry. 1984;23:6544–6549.
28. Imanishi Y, Sun W, Maeda T, Maeda A, Palczewski K. Retinyl ester homeostasis in the adipose differentiation-related protein- deficient retina. J Biol Chem. 2008;283:25091–25102.
29. Nemet I, Tian G, Imanishi Y. Submembrane assembly and renewal of rod photoreceptor cGMP-gated channel: insight into the actin-dependent process of outer segment morphogenesis. J Neurosci. 2014;34:8164–8174.
30. Stockton RA, Slaughter MM. B-wave of the electroretinogram. A reflection of ON bipolar cell activity. J Gen Physiol. 1989;93: 101–122.
31. Breton ME, Schueller AW, Lamb TD, Pugh EN Jr. Analysis of ERG a-wave amplification and kinetics in terms of the Gprotein cascade of phototransduction. Invest Ophthalmol Vis Sci. 1994;35:295–309.
32. Wang JS, Nymark S, Frederiksen R, et al. Chromophore supply rate-limits mammalian photoreceptor dark adaptation. J Neurosci. 2014;34:11212–11221.
33. Sokolov M, Lyubarsky AL, Strissel KJ, et al. Massive light-driven translocation of transducin between the two major compartments of rod cells: a novel mechanism of light adaptation. Neuron. 2002;34:95–106.
34. Strissel KJ, Sokolov M, Trieu LH, Arshavsky VY. Arrestin translocation is induced at a critical threshold of visual signaling and is superstoichiometric to bleached rhodopsin. J Neurosci. 2006;26:1146–1153.
35. Maerker T, van Wijk E, Overlack N, et al. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum Mol Genet. 2008;17:71–86.
36. Sterling P, Matthews G. Structure and function of ribbon synapses. Trends Neurosci. 2005;28:20–29.
37. Lodowski KH, Lee R, Ropelewski P, Nemet I, Tian G, Imanishi Y. Signals governing the trafficking and mistrafficking of a ciliary GPCR, rhodopsin. J Neurosci. 2013;33:13621–13638.
38. Nemet I, Ropelewski P, Imanishi Y. Rhodopsin trafficking and mistrafficking: signals, molecular components, and mechanisms. Prog Mol Biol Transl Sci. 2015;132:39–71.
39. Tian G, Ropelewski P, Nemet I, Lee R, Lodowski KH, Imanishi Y. An unconventional secretory pathway mediates the cilia targeting of peripherin/rds. J Neurosci. 2014;34:992–1006.
40. Higuchi H, Macke EL, Lee WH, et al. Genetic basis of agedependent synaptic abnormalities in the retina. Mamm Genome. 2015;26:21–32.
41. Koulen P, Fletcher EL, Craven SE, Bredt DS, Wassle H. Immunocytochemical localization of the postsynaptic density protein PSD-95 in the mammalian retina. J Neurosci. 1998;18: 10136–10149.
42. Haverkamp S, Wassle H. Immunocytochemical analysis of the mouse retina. J Comp Neurol. 2000;424:1–23.
43. Haeseleer F, Imanishi Y, Maeda T, et al. Essential role of Ca2þbinding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci. 2004;7:1079–1087.
44. Adato A, Kalinski H, Weil D, Chaib H, Korostishevsky M, Bonne-Tamir B. Possible interaction between USH1B and USH3 gene products as implied by apparent digenic deafness inheritance. Am J Hum Genet. 1999;65:261–265.
45. Hasson T, Heintzelman MB, Santos-Sacchi J, Corey DP, Mooseker MS. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc Natl Acad Sci U S A. 1995;92:9815–9819.
46. Gopal SR, Chen DH, Chou SW, et al. Zebrafish models for the mechanosensory hair cell dysfunction in usher syndrome 3 reveal that clarin-1 is an essential hair bundle protein. J Neurosci. 2015;35:10188–10201.